MedPath

The Usefulness and Hemodynamic Effect of Landiolol Treatment to Control Atrial Tachyarrhythmia in Patients with Heart Failure with Reduced Ejection Fraction in The Acute Phase

Not Applicable
Conditions
The patients with heart failure with reduced ejection fraction(EF&lt
40%) who have rapid atrial tachyarrhythmia in the acute phase of acute decompensated heart failure.
Registration Number
JPRN-UMIN000020084
Lead Sponsor
Yokohama City University Medical Center
Brief Summary

Circ Rep. 2019 Sep 26;1(10):422-430. doi: 10.1253/circrep.CR-19-0076. J Cardiol. 2022 Jan;79(1):21-29. doi: 10.1016/j.jjcc.2021.09.008. Epub 2021 Sep 2

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
115
Inclusion Criteria

Not provided

Exclusion Criteria

1.extremely hemodynamically disruption 2.no standard treatment for heart failure 3.excess dehydration or abnormal electrolysis without any appropriate treatment 4.systolic blood pressure <80mmHg 5.apparent cardiogenic shock 6.pregnant 7.thyroid or adrenal disease

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Heart rate reduction and hemodynamic improvements
Secondary Outcome Measures
NameTimeMethod
Safety Prognosis and examine the role of HR reduction on the prognosis.
© Copyright 2025. All Rights Reserved by MedPath